|
Castillo, G M; Lukito, W; Peskind, E et al. (2000) Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain. J Neurosci Res 62:451-62
|
|
Castillo, G M; Lukito, W; Wight, T N et al. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J Neurochem 72:1681-7
|
|
Castillo, G M; Cummings, J A; Yang, W et al. (1998) Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 47:612-20
|
|
Castillo, G M; Ngo, C; Cummings, J et al. (1997) Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem 69:2452-65
|
|
Miller, J D; Cummings, J; Maresh, G A et al. (1997) Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus. Glia 21:228-43
|
|
Castillo, G M; Cummings, J A; Ngo, C et al. (1996) Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar A beta amyloid persistence in brain. J Biochem 120:433-44
|
|
Maresh, G A; Erezyilmaz, D; Murry, C E et al. (1996) Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction. J Neurochem 67:1132-44
|
